Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
Low
0.27
High
1.10
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Sernova Corp | SVA | Toronto | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.025 | 8.06% | 0.335 | 12:51:39 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.315 | 0.31 | 0.34 | 0.31 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 34 | 146,150 | - | 0.27 - 1.10 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 12:51:39 | 5,500 | $ 0.335 | CAD |
Sernova Corp Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 100.1M | 303.33M | - | 0 | -39M | -0.13 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Sernova News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/06/2024 | 15:17 | PR Newswire (Canada) | Sernova Announces Marketed Public Offering of Units |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SVA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.31 | 0.36 | 0.27 | 0.322751 | 396,357 | 0.025 | 8.06% |
| 1 Month | 0.315 | 0.40 | 0.27 | 0.3236974 | 210,549 | 0.02 | 6.35% |
| 3 Months | 0.55 | 0.60 | 0.27 | 0.389679 | 174,528 | -0.215 | -39.09% |
| 6 Months | 0.68 | 0.73 | 0.27 | 0.5044771 | 156,895 | -0.345 | -50.74% |
| 1 Year | 0.87 | 1.10 | 0.27 | 0.6208461 | 123,633 | -0.535 | -61.49% |
| 3 Years | 1.55 | 1.59 | 0.27 | 0.8179928 | 122,720 | -1.22 | -78.39% |
| 5 Years | 1.55 | 1.59 | 0.27 | 0.8179928 | 122,720 | -1.22 | -78.39% |
Sernova Description
| Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. |
